Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
This is an increase over the number of companies cited in the previous quarter.
The citations in the county include:
- The design was not validated under defined operating conditions and using initial production units, lots or batches or their equivalents.
- Risk analysis is incomplete.
- Procedures for design change have not been adequately established.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Zoe Medical Incorporated | Devices | 05/31/2024 | Design validation - production units |
Zoe Medical Incorporated | Devices | 05/31/2024 | Design Validation - Risk analysis not performed/inadequate |
Zoe Medical Incorporated | Devices | 05/31/2024 | Design changes - Lack of or Inadequate Procedures |
Zoe Medical Incorporated | Devices | 05/31/2024 | Evaluation of suppliers, contractors, etc., requirements |
Zoe Medical Incorporated | Devices | 05/31/2024 | Lack of or inadequate procedures |